- Home
- ALIT vs PHAR Comparison
ALIT vs PHAR Comparison
Compare ALIT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALIT
- PHAR
- Stock Information
- Founded
- ALIT 2017
- PHAR 1988
- Country
- ALIT United States
- PHAR Netherlands
- Employees
- ALIT N/A
- PHAR N/A
- Industry
- ALIT Business Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- ALIT Consumer Discretionary
- PHAR Health Care
- Exchange
- ALIT Nasdaq
- PHAR Nasdaq
- Market Cap
- ALIT 1.1B
- PHAR 951.7M
- IPO Year
- ALIT N/A
- PHAR N/A
- Fundamental
- Price
- ALIT $2.25
- PHAR $17.07
- Analyst Decision
- ALIT Strong Buy
- PHAR Strong Buy
- Analyst Count
- ALIT 4
- PHAR 3
- Target Price
- ALIT $5.25
- PHAR $30.00
- AVG Volume (30 Days)
- ALIT 13.7M
- PHAR 19.8K
- Earning Date
- ALIT 11-05-2025
- PHAR 11-06-2025
- Dividend Yield
- ALIT 7.14%
- PHAR N/A
- EPS Growth
- ALIT N/A
- PHAR N/A
- EPS
- ALIT N/A
- PHAR 0.00
- Revenue
- ALIT $2,289,000,000.00
- PHAR $362,274,000.00
- Revenue This Year
- ALIT $0.51
- PHAR $17.70
- Revenue Next Year
- ALIT $2.39
- PHAR $12.25
- P/E Ratio
- ALIT N/A
- PHAR $3,068.84
- Revenue Growth
- ALIT N/A
- PHAR 26.78
- 52 Week Low
- ALIT $1.89
- PHAR $7.35
- 52 Week High
- ALIT $8.21
- PHAR $17.76
- Technical
- Relative Strength Index (RSI)
- ALIT 37.62
- PHAR 60.37
- Support Level
- ALIT $1.89
- PHAR $15.81
- Resistance Level
- ALIT $2.05
- PHAR $17.50
- Average True Range (ATR)
- ALIT 0.14
- PHAR 0.91
- MACD
- ALIT 0.01
- PHAR 0.09
- Stochastic Oscillator
- ALIT 52.21
- PHAR 80.47
About ALIT Alight Inc.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.